BRPI0914609A2 - material matriz extracelular isolado incluindo fascia subserosa - Google Patents

material matriz extracelular isolado incluindo fascia subserosa

Info

Publication number
BRPI0914609A2
BRPI0914609A2 BRPI0914609A BRPI0914609A BRPI0914609A2 BR PI0914609 A2 BRPI0914609 A2 BR PI0914609A2 BR PI0914609 A BRPI0914609 A BR PI0914609A BR PI0914609 A BRPI0914609 A BR PI0914609A BR PI0914609 A2 BRPI0914609 A2 BR PI0914609A2
Authority
BR
Brazil
Prior art keywords
matrix material
extracellular matrix
material including
isolated extracellular
subserous fascia
Prior art date
Application number
BRPI0914609A
Other languages
English (en)
Inventor
Bhavin Shah
Katie L Harrigan
Original Assignee
Cook Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Biotech Inc filed Critical Cook Biotech Inc
Publication of BRPI0914609A2 publication Critical patent/BRPI0914609A2/pt
Publication of BRPI0914609B1 publication Critical patent/BRPI0914609B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
BRPI0914609A 2008-07-01 2009-06-29 material de enxerto de matriz extracelular de elastina e colágeno bio-reabsorvível tendo alta elasticidade e resistência, bem como seu processo de preparação BRPI0914609B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7742308P 2008-07-01 2008-07-01
PCT/US2009/049079 WO2010002799A2 (en) 2008-07-01 2009-06-29 Isolated extracellular matrix material including subserous fascia

Publications (2)

Publication Number Publication Date
BRPI0914609A2 true BRPI0914609A2 (pt) 2015-12-08
BRPI0914609B1 BRPI0914609B1 (pt) 2018-08-28

Family

ID=41119300

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914609A BRPI0914609B1 (pt) 2008-07-01 2009-06-29 material de enxerto de matriz extracelular de elastina e colágeno bio-reabsorvível tendo alta elasticidade e resistência, bem como seu processo de preparação

Country Status (8)

Country Link
US (2) US8541372B2 (pt)
EP (1) EP2310061B1 (pt)
JP (1) JP2011526811A (pt)
CN (1) CN102176929B (pt)
AU (1) AU2009267181A1 (pt)
BR (1) BRPI0914609B1 (pt)
CA (1) CA2728553C (pt)
WO (1) WO2010002799A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009267181A1 (en) * 2008-07-01 2010-01-07 Cook Biotech Incorporated Isolated extracellular matrix material including subserous fascia
KR101446265B1 (ko) * 2011-10-17 2014-11-03 메디칸(주) 면역성이 제거된 생체지방소재 및 이의 제조방법
EP2806907B1 (en) * 2012-01-24 2018-11-21 LifeCell Corporation Elongated tissue matrices
US11090338B2 (en) 2012-07-13 2021-08-17 Lifecell Corporation Methods for improved treatment of adipose tissue
EP3332816B1 (en) * 2012-09-26 2020-11-04 LifeCell Corporation Processed adipose tissue
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
EP3383444B1 (en) * 2015-12-02 2020-05-20 Cook Biotech Incorporated Filamentous graft implants and methods of their manufacture and use
WO2017100625A2 (en) 2015-12-10 2017-06-15 Cook Biotech Incorporated Poly(ester urea) fiber devices and related methods
CN105664257B (zh) * 2016-03-01 2019-02-19 上海卓阮医疗科技有限公司 一种修复区稳固的复合软组织修复材料
CN105920669B (zh) * 2016-04-25 2019-03-29 上海卓阮医疗科技有限公司 一种复合细胞外基质成分生物材料
EP3308829B1 (en) 2016-09-10 2020-04-29 Cook Biotech Incorporated Electrostimulative graft products
EP3573675A1 (en) * 2017-01-30 2019-12-04 LifeCell Corporation Tissue matrix materials and enzymatic adhesives
AU2018212910A1 (en) * 2017-01-30 2019-08-01 Lifecell Corporation Devices including muscle matrix and methods of production and use
EP3573674A1 (en) 2017-01-30 2019-12-04 LifeCell Corporation Transglutaminase treated products
EP4046667A1 (en) 2017-03-06 2022-08-24 Tei Biosciences, Inc. Perforated tissue graft
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
US11826490B1 (en) 2020-12-29 2023-11-28 Acell, Inc. Extracellular matrix sheet devices with improved mechanical properties and method of making
CN114796606B (zh) * 2021-01-20 2024-03-01 南方医科大学南方医院 一种刚性脂肪移植复合材料及其制备方法与应用
WO2025048835A1 (en) 2023-09-01 2025-03-06 Bhavin Shah Polycaprolactone-based fibers and implants including same

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) * 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US2167251A (en) * 1938-08-20 1939-07-25 Davis & Geck Inc Surgical tape of submucosa tissue
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4321914A (en) * 1980-04-22 1982-03-30 W. L. Gore & Associates, Inc. Percutaneous conduit having PTFE skirt
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4755593A (en) * 1985-07-24 1988-07-05 Lauren Mark D Novel biomaterial of cross-linked peritoneal tissue
US4969902A (en) * 1987-02-20 1990-11-13 Biagio Ravo Implantable device
US4781176A (en) * 1987-02-20 1988-11-01 Biagio Ravo Implantable device
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4956178A (en) * 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US5281422A (en) * 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5269774A (en) * 1992-09-25 1993-12-14 Gray Michael W Implantive ostomy ring
US6475232B1 (en) * 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
US5711969A (en) * 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5554389A (en) * 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
SK22499A3 (en) * 1996-08-23 1999-10-08 Cook Biotech Inc Graft prosthesis, materials and methods
DE69720252T2 (de) * 1996-12-10 2003-12-04 Purdue Research Foundation, West Lafayette Gewebetransplantat aus der magensubmukosa
AU732726B2 (en) * 1996-12-10 2001-04-26 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6371992B1 (en) * 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
EP1210046A4 (en) * 1999-06-22 2007-05-02 Res Dev Foundation IMPROVED DRESSING THAT CAN ACCELERATE THE HEALING OF INJURIES
JP4426285B2 (ja) * 2001-06-28 2010-03-03 クック・バイオテック・インコーポレーテッド 腎被膜コラーゲンを含有する移植片プロテーゼ用具
AU2003260086A1 (en) * 2002-04-01 2003-10-20 Board Of Regents, The University Of Texas System Composite material for wound repair
CA2565203A1 (en) * 2004-03-31 2005-10-20 Cook Incorporated Ecm-based graft material
US7244444B2 (en) * 2004-03-31 2007-07-17 Cook Incorporated Graft material, stent graft and method
US20060073592A1 (en) * 2004-10-06 2006-04-06 Wendell Sun Methods of storing tissue matrices
WO2006050459A2 (en) * 2004-10-28 2006-05-11 Cook Incorporated Methods and systems for modifying vascular valves
JP4995811B2 (ja) * 2005-04-29 2012-08-08 クック・バイオテック・インコーポレーテッド 瘻治療用容積式移植片並びに関連の方法及びシステム
US7670762B2 (en) * 2006-01-17 2010-03-02 Brennen Medical, Llc Biocompatible tissue graft material for implant and method of making
EP2079490B1 (en) * 2006-10-23 2012-08-29 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
US20100082113A1 (en) 2008-04-29 2010-04-01 Peter Gingras Tissue repair implant
AU2009267181A1 (en) * 2008-07-01 2010-01-07 Cook Biotech Incorporated Isolated extracellular matrix material including subserous fascia

Also Published As

Publication number Publication date
CN102176929A (zh) 2011-09-07
CA2728553A1 (en) 2010-01-07
US20110152196A1 (en) 2011-06-23
JP2011526811A (ja) 2011-10-20
US9044455B2 (en) 2015-06-02
EP2310061B1 (en) 2014-10-08
EP2310061A2 (en) 2011-04-20
CN102176929B (zh) 2014-03-26
BRPI0914609B1 (pt) 2018-08-28
WO2010002799A3 (en) 2010-08-12
CA2728553C (en) 2016-08-16
US8541372B2 (en) 2013-09-24
AU2009267181A1 (en) 2010-01-07
US20130310322A1 (en) 2013-11-21
WO2010002799A2 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
BRPI0914609A2 (pt) material matriz extracelular isolado incluindo fascia subserosa
BRPI0918734A2 (pt) material polimérico
BRPI0906972A2 (pt) Composições de matriz extracelular.
EP2045283A4 (en) HIGH REFRACTIVE INDEX MATERIAL
HRP20151120T1 (xx) Polipeptid ace2
EP2193769A4 (en) Patch material
BRPI0920905A2 (pt) material absorvente
DK2214504T3 (da) Amfifilt polymert materiale
BRPI0811116A2 (pt) Material protetor.
PL394116A1 (pl) Sortowanie materiału urobkowego
DK2252395T3 (da) Afsvovlingsmaterialer
BRPI0908382A2 (pt) Material reforçado
DE602008001850D1 (de) Blattzuführungsanordnung
BRPI0909036A2 (pt) pesticidas
BRPI0921487A2 (pt) triturador cônico
EP2127730A4 (en) CATALYST MATERIAL
DK2382224T3 (da) Metalhydracid-materialer
DE602008002123D1 (de) Materialzufuhrvorrichtung
FI20075212L (fi) Muovattava biohajoava materiaali
ATE556106T1 (de) Lederwerkstoff
BRPI1011283A2 (pt) material de folha de liberação
DE502008001891D1 (de) Kantenmaterial
DE502008003022D1 (de) Häcksler
EP2130922A4 (en) IMPROVED HALOHYDRIN EPOXIDASE
EE00792U1 (et) Katusekattematerjal

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/06/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2677 DE 26-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.